Randomised clinical trial: safety, tolerability, pharmacokinetics and pharmacodynamics of repeated doses of TAK‐438 (vonoprazan), a novel potassium‐competitive acid blocker, in healthy male subjects

Supporters

Support the authors with ResearchCoin

Tip RSC

Journal

Alimentary Pharmacology & Therapeutics

Topics

Medicine

Pathology

Internal Medicine

Surgery

Gastroenterology

Show all topics

DOI

10.1111/apt.13121

License

CC-BY-NC-ND

Other Formats

PDF